Search

Your search keyword '"Meurice, Nathalie"' showing total 222 results
Start Over Author "Meurice, Nathalie"
222 results on '"Meurice, Nathalie"'

1. FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations

Author

Uson Junior, Pedro Luiz Serrano, DeLeon, Thomas T., Bogenberger, James M., Pai, Rish K., Kosiorek, Heidi E., Yin, Jun, Ahn, Daniel H., Sonbol, Mohammad Bassam, Bekaii-Saab, Tanios, Mansfield, Aaron S., Buetow, Kenneth, Gores, Gregory J., Smoot, Rory, Vasmatzis, George, Kipp, Benjamin R., Mahipal, Amit, Baker, Alexander T., Babiker, Hani, Barro, Oumar, Dumbauld, Chelsae, Zhou, Yumei, Aslam, Faaiq N., Barrett, Michael, Jacobs, Bertram, Meurice, Nathalie, Arora, Mansi, Petit, Joachim, Elliott, Natalie, Nagalo, Bolni, Salomao, Marcela A., and Borad, Mitesh J.

Published
2022
Full Text
View/download PDF

3. Supplementary Figure 6 from Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer

Author

Kase, Adam M., primary, Gleba, Justyna, primary, Miller, James L., primary, Miller, Erin, primary, Petit, Joachim, primary, Barrett, Michael T., primary, Zhou, Yumei, primary, Parent, Ephraim E., primary, Cai, Hancheng, primary, Knight, Joshua A., primary, Orme, Jacob, primary, Reynolds, Jordan, primary, Durham, William F., primary, Metz, Thomas M., primary, Meurice, Nathalie, primary, Edenfield, Brandy, primary, Alasonyalilar Demirer, Aylin, primary, Bilgili, Ahmet, primary, Hickman, Peyton G., primary, Pawlush, Matthew L., primary, Marlow, Laura, primary, Wickland, Daniel P., primary, Tan, Winston, primary, and Copland, John A., primary

Published
2024
Full Text
View/download PDF

4. Supplementary Figure 4 from Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer

Author

Kase, Adam M., primary, Gleba, Justyna, primary, Miller, James L., primary, Miller, Erin, primary, Petit, Joachim, primary, Barrett, Michael T., primary, Zhou, Yumei, primary, Parent, Ephraim E., primary, Cai, Hancheng, primary, Knight, Joshua A., primary, Orme, Jacob, primary, Reynolds, Jordan, primary, Durham, William F., primary, Metz, Thomas M., primary, Meurice, Nathalie, primary, Edenfield, Brandy, primary, Alasonyalilar Demirer, Aylin, primary, Bilgili, Ahmet, primary, Hickman, Peyton G., primary, Pawlush, Matthew L., primary, Marlow, Laura, primary, Wickland, Daniel P., primary, Tan, Winston, primary, and Copland, John A., primary

Published
2024
Full Text
View/download PDF

5. Data from Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer

Author

Kase, Adam M., primary, Gleba, Justyna, primary, Miller, James L., primary, Miller, Erin, primary, Petit, Joachim, primary, Barrett, Michael T., primary, Zhou, Yumei, primary, Parent, Ephraim E., primary, Cai, Hancheng, primary, Knight, Joshua A., primary, Orme, Jacob, primary, Reynolds, Jordan, primary, Durham, William F., primary, Metz, Thomas M., primary, Meurice, Nathalie, primary, Edenfield, Brandy, primary, Alasonyalilar Demirer, Aylin, primary, Bilgili, Ahmet, primary, Hickman, Peyton G., primary, Pawlush, Matthew L., primary, Marlow, Laura, primary, Wickland, Daniel P., primary, Tan, Winston, primary, and Copland, John A., primary

Published
2024
Full Text
View/download PDF

6. Supplementary Figure 1 from Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer

Author

Kase, Adam M., primary, Gleba, Justyna, primary, Miller, James L., primary, Miller, Erin, primary, Petit, Joachim, primary, Barrett, Michael T., primary, Zhou, Yumei, primary, Parent, Ephraim E., primary, Cai, Hancheng, primary, Knight, Joshua A., primary, Orme, Jacob, primary, Reynolds, Jordan, primary, Durham, William F., primary, Metz, Thomas M., primary, Meurice, Nathalie, primary, Edenfield, Brandy, primary, Alasonyalilar Demirer, Aylin, primary, Bilgili, Ahmet, primary, Hickman, Peyton G., primary, Pawlush, Matthew L., primary, Marlow, Laura, primary, Wickland, Daniel P., primary, Tan, Winston, primary, and Copland, John A., primary

Published
2024
Full Text
View/download PDF

7. Supplementary Figure 5 from Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer

Author

Kase, Adam M., primary, Gleba, Justyna, primary, Miller, James L., primary, Miller, Erin, primary, Petit, Joachim, primary, Barrett, Michael T., primary, Zhou, Yumei, primary, Parent, Ephraim E., primary, Cai, Hancheng, primary, Knight, Joshua A., primary, Orme, Jacob, primary, Reynolds, Jordan, primary, Durham, William F., primary, Metz, Thomas M., primary, Meurice, Nathalie, primary, Edenfield, Brandy, primary, Alasonyalilar Demirer, Aylin, primary, Bilgili, Ahmet, primary, Hickman, Peyton G., primary, Pawlush, Matthew L., primary, Marlow, Laura, primary, Wickland, Daniel P., primary, Tan, Winston, primary, and Copland, John A., primary

Published
2024
Full Text
View/download PDF

8. Supplementary Figure 3 from Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer

Author

Kase, Adam M., primary, Gleba, Justyna, primary, Miller, James L., primary, Miller, Erin, primary, Petit, Joachim, primary, Barrett, Michael T., primary, Zhou, Yumei, primary, Parent, Ephraim E., primary, Cai, Hancheng, primary, Knight, Joshua A., primary, Orme, Jacob, primary, Reynolds, Jordan, primary, Durham, William F., primary, Metz, Thomas M., primary, Meurice, Nathalie, primary, Edenfield, Brandy, primary, Alasonyalilar Demirer, Aylin, primary, Bilgili, Ahmet, primary, Hickman, Peyton G., primary, Pawlush, Matthew L., primary, Marlow, Laura, primary, Wickland, Daniel P., primary, Tan, Winston, primary, and Copland, John A., primary

Published
2024
Full Text
View/download PDF

9. Supplementary Figure 7 from Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer

Author

Kase, Adam M., primary, Gleba, Justyna, primary, Miller, James L., primary, Miller, Erin, primary, Petit, Joachim, primary, Barrett, Michael T., primary, Zhou, Yumei, primary, Parent, Ephraim E., primary, Cai, Hancheng, primary, Knight, Joshua A., primary, Orme, Jacob, primary, Reynolds, Jordan, primary, Durham, William F., primary, Metz, Thomas M., primary, Meurice, Nathalie, primary, Edenfield, Brandy, primary, Alasonyalilar Demirer, Aylin, primary, Bilgili, Ahmet, primary, Hickman, Peyton G., primary, Pawlush, Matthew L., primary, Marlow, Laura, primary, Wickland, Daniel P., primary, Tan, Winston, primary, and Copland, John A., primary

Published
2024
Full Text
View/download PDF

10. Supplementary Figure 2 from Patient-Derived Tumor Xenograft Study with CDK4/6 Inhibitor Plus AKT Inhibitor for the Management of Metastatic Castration-Resistant Prostate Cancer

Author

Kase, Adam M., primary, Gleba, Justyna, primary, Miller, James L., primary, Miller, Erin, primary, Petit, Joachim, primary, Barrett, Michael T., primary, Zhou, Yumei, primary, Parent, Ephraim E., primary, Cai, Hancheng, primary, Knight, Joshua A., primary, Orme, Jacob, primary, Reynolds, Jordan, primary, Durham, William F., primary, Metz, Thomas M., primary, Meurice, Nathalie, primary, Edenfield, Brandy, primary, Alasonyalilar Demirer, Aylin, primary, Bilgili, Ahmet, primary, Hickman, Peyton G., primary, Pawlush, Matthew L., primary, Marlow, Laura, primary, Wickland, Daniel P., primary, Tan, Winston, primary, and Copland, John A., primary

Published
2024
Full Text
View/download PDF

12. Patient-derived tumor xenograft study with CDK4/6 inhibitor plus AKT inhibitor for the management of metastatic castration-resistant prostate cancer

Author

Kase, Adam M., primary, Gleba, Justyna, additional, Miller, James L., additional, Miller, Erin, additional, Petit, Joachim, additional, Barrett, Michael T., additional, Zhou, Yumei, additional, Parent, Ephraim E., additional, Cai, Hancheng, additional, Knight, Joshua A., additional, Orme, Jacob, additional, Reynolds, Jordan, additional, Durham, William F., additional, Metz, Thomas M., additional, Meurice, Nathalie, additional, Edenfield, Brandy, additional, Alasonyalilar Demirer, Aylin, additional, Bilgili, Ahmet, additional, Hickman, Peyton G., additional, Pawlush, Matthew L., additional, Marlow, Laura, additional, Wickland, Daniel P., additional, Tan, Winston, additional, and Copland, John A., additional

Published
2024
Full Text
View/download PDF

13. Supplementary Table 1 from Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma

Author

Welsh, Seth J., primary, Barwick, Benjamin G., primary, Meermeier, Erin W., primary, Riggs, Daniel L., primary, Shi, Chang-Xin, primary, Zhu, Yuan Xiao, primary, Sharik, Meaghen E., primary, Du, Megan T., primary, Abrego Rocha, Leslie D., primary, Garbitt, Victoria M., primary, Stein, Caleb K., primary, Petit, Joachim L., primary, Meurice, Nathalie, primary, Tafoya Alvarado, Yuliza, primary, Fonseca, Rodrigo, primary, Todd, Kennedi T., primary, Brown, Sochilt, primary, Hammond, Zachery J., primary, Cuc, Nicklus H., primary, Wittenberg, Courtney, primary, Herzog, Camille, primary, Roschke, Anna V., primary, Demchenko, Yulia N., primary, Chen, Wei-dong D., primary, Li, Peng, primary, Liao, Wei, primary, Leonard, Warren J., primary, Lonial, Sagar, primary, Bahlis, Nizar J., primary, Neri, Paola, primary, Boise, Lawrence H., primary, Chesi, Marta, primary, and Bergsagel, P. Leif, primary

Published
2024
Full Text
View/download PDF

14. Supplementary Data 4 from Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma

Author

Welsh, Seth J., primary, Barwick, Benjamin G., primary, Meermeier, Erin W., primary, Riggs, Daniel L., primary, Shi, Chang-Xin, primary, Zhu, Yuan Xiao, primary, Sharik, Meaghen E., primary, Du, Megan T., primary, Abrego Rocha, Leslie D., primary, Garbitt, Victoria M., primary, Stein, Caleb K., primary, Petit, Joachim L., primary, Meurice, Nathalie, primary, Tafoya Alvarado, Yuliza, primary, Fonseca, Rodrigo, primary, Todd, Kennedi T., primary, Brown, Sochilt, primary, Hammond, Zachery J., primary, Cuc, Nicklus H., primary, Wittenberg, Courtney, primary, Herzog, Camille, primary, Roschke, Anna V., primary, Demchenko, Yulia N., primary, Chen, Wei-dong D., primary, Li, Peng, primary, Liao, Wei, primary, Leonard, Warren J., primary, Lonial, Sagar, primary, Bahlis, Nizar J., primary, Neri, Paola, primary, Boise, Lawrence H., primary, Chesi, Marta, primary, and Bergsagel, P. Leif, primary

Published
2024
Full Text
View/download PDF

15. Supplementary Data 3 from Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma

Author

Welsh, Seth J., primary, Barwick, Benjamin G., primary, Meermeier, Erin W., primary, Riggs, Daniel L., primary, Shi, Chang-Xin, primary, Zhu, Yuan Xiao, primary, Sharik, Meaghen E., primary, Du, Megan T., primary, Abrego Rocha, Leslie D., primary, Garbitt, Victoria M., primary, Stein, Caleb K., primary, Petit, Joachim L., primary, Meurice, Nathalie, primary, Tafoya Alvarado, Yuliza, primary, Fonseca, Rodrigo, primary, Todd, Kennedi T., primary, Brown, Sochilt, primary, Hammond, Zachery J., primary, Cuc, Nicklus H., primary, Wittenberg, Courtney, primary, Herzog, Camille, primary, Roschke, Anna V., primary, Demchenko, Yulia N., primary, Chen, Wei-dong D., primary, Li, Peng, primary, Liao, Wei, primary, Leonard, Warren J., primary, Lonial, Sagar, primary, Bahlis, Nizar J., primary, Neri, Paola, primary, Boise, Lawrence H., primary, Chesi, Marta, primary, and Bergsagel, P. Leif, primary

Published
2024
Full Text
View/download PDF

16. Data from Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma

Author

Welsh, Seth J., primary, Barwick, Benjamin G., primary, Meermeier, Erin W., primary, Riggs, Daniel L., primary, Shi, Chang-Xin, primary, Zhu, Yuan Xiao, primary, Sharik, Meaghen E., primary, Du, Megan T., primary, Abrego Rocha, Leslie D., primary, Garbitt, Victoria M., primary, Stein, Caleb K., primary, Petit, Joachim L., primary, Meurice, Nathalie, primary, Tafoya Alvarado, Yuliza, primary, Fonseca, Rodrigo, primary, Todd, Kennedi T., primary, Brown, Sochilt, primary, Hammond, Zachery J., primary, Cuc, Nicklus H., primary, Wittenberg, Courtney, primary, Herzog, Camille, primary, Roschke, Anna V., primary, Demchenko, Yulia N., primary, Chen, Wei-dong D., primary, Li, Peng, primary, Liao, Wei, primary, Leonard, Warren J., primary, Lonial, Sagar, primary, Bahlis, Nizar J., primary, Neri, Paola, primary, Boise, Lawrence H., primary, Chesi, Marta, primary, and Bergsagel, P. Leif, primary

Published
2024
Full Text
View/download PDF

17. Supplementary Table 2 from Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma

Author

Welsh, Seth J., primary, Barwick, Benjamin G., primary, Meermeier, Erin W., primary, Riggs, Daniel L., primary, Shi, Chang-Xin, primary, Zhu, Yuan Xiao, primary, Sharik, Meaghen E., primary, Du, Megan T., primary, Abrego Rocha, Leslie D., primary, Garbitt, Victoria M., primary, Stein, Caleb K., primary, Petit, Joachim L., primary, Meurice, Nathalie, primary, Tafoya Alvarado, Yuliza, primary, Fonseca, Rodrigo, primary, Todd, Kennedi T., primary, Brown, Sochilt, primary, Hammond, Zachery J., primary, Cuc, Nicklus H., primary, Wittenberg, Courtney, primary, Herzog, Camille, primary, Roschke, Anna V., primary, Demchenko, Yulia N., primary, Chen, Wei-dong D., primary, Li, Peng, primary, Liao, Wei, primary, Leonard, Warren J., primary, Lonial, Sagar, primary, Bahlis, Nizar J., primary, Neri, Paola, primary, Boise, Lawrence H., primary, Chesi, Marta, primary, and Bergsagel, P. Leif, primary

Published
2024
Full Text
View/download PDF

18. Supplementary Data 1 from Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma

Author

Welsh, Seth J., primary, Barwick, Benjamin G., primary, Meermeier, Erin W., primary, Riggs, Daniel L., primary, Shi, Chang-Xin, primary, Zhu, Yuan Xiao, primary, Sharik, Meaghen E., primary, Du, Megan T., primary, Abrego Rocha, Leslie D., primary, Garbitt, Victoria M., primary, Stein, Caleb K., primary, Petit, Joachim L., primary, Meurice, Nathalie, primary, Tafoya Alvarado, Yuliza, primary, Fonseca, Rodrigo, primary, Todd, Kennedi T., primary, Brown, Sochilt, primary, Hammond, Zachery J., primary, Cuc, Nicklus H., primary, Wittenberg, Courtney, primary, Herzog, Camille, primary, Roschke, Anna V., primary, Demchenko, Yulia N., primary, Chen, Wei-dong D., primary, Li, Peng, primary, Liao, Wei, primary, Leonard, Warren J., primary, Lonial, Sagar, primary, Bahlis, Nizar J., primary, Neri, Paola, primary, Boise, Lawrence H., primary, Chesi, Marta, primary, and Bergsagel, P. Leif, primary

Published
2024
Full Text
View/download PDF

19. Supplementary Data 2 from Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma

Author

Welsh, Seth J., primary, Barwick, Benjamin G., primary, Meermeier, Erin W., primary, Riggs, Daniel L., primary, Shi, Chang-Xin, primary, Zhu, Yuan Xiao, primary, Sharik, Meaghen E., primary, Du, Megan T., primary, Abrego Rocha, Leslie D., primary, Garbitt, Victoria M., primary, Stein, Caleb K., primary, Petit, Joachim L., primary, Meurice, Nathalie, primary, Tafoya Alvarado, Yuliza, primary, Fonseca, Rodrigo, primary, Todd, Kennedi T., primary, Brown, Sochilt, primary, Hammond, Zachery J., primary, Cuc, Nicklus H., primary, Wittenberg, Courtney, primary, Herzog, Camille, primary, Roschke, Anna V., primary, Demchenko, Yulia N., primary, Chen, Wei-dong D., primary, Li, Peng, primary, Liao, Wei, primary, Leonard, Warren J., primary, Lonial, Sagar, primary, Bahlis, Nizar J., primary, Neri, Paola, primary, Boise, Lawrence H., primary, Chesi, Marta, primary, and Bergsagel, P. Leif, primary

Published
2024
Full Text
View/download PDF

20. Supplementary Data 5 from Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma

Author

Welsh, Seth J., primary, Barwick, Benjamin G., primary, Meermeier, Erin W., primary, Riggs, Daniel L., primary, Shi, Chang-Xin, primary, Zhu, Yuan Xiao, primary, Sharik, Meaghen E., primary, Du, Megan T., primary, Abrego Rocha, Leslie D., primary, Garbitt, Victoria M., primary, Stein, Caleb K., primary, Petit, Joachim L., primary, Meurice, Nathalie, primary, Tafoya Alvarado, Yuliza, primary, Fonseca, Rodrigo, primary, Todd, Kennedi T., primary, Brown, Sochilt, primary, Hammond, Zachery J., primary, Cuc, Nicklus H., primary, Wittenberg, Courtney, primary, Herzog, Camille, primary, Roschke, Anna V., primary, Demchenko, Yulia N., primary, Chen, Wei-dong D., primary, Li, Peng, primary, Liao, Wei, primary, Leonard, Warren J., primary, Lonial, Sagar, primary, Bahlis, Nizar J., primary, Neri, Paola, primary, Boise, Lawrence H., primary, Chesi, Marta, primary, and Bergsagel, P. Leif, primary

Published
2024
Full Text
View/download PDF

21. Supplementary Figures S1-S11 from Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma

Author

Welsh, Seth J., primary, Barwick, Benjamin G., primary, Meermeier, Erin W., primary, Riggs, Daniel L., primary, Shi, Chang-Xin, primary, Zhu, Yuan Xiao, primary, Sharik, Meaghen E., primary, Du, Megan T., primary, Abrego Rocha, Leslie D., primary, Garbitt, Victoria M., primary, Stein, Caleb K., primary, Petit, Joachim L., primary, Meurice, Nathalie, primary, Tafoya Alvarado, Yuliza, primary, Fonseca, Rodrigo, primary, Todd, Kennedi T., primary, Brown, Sochilt, primary, Hammond, Zachery J., primary, Cuc, Nicklus H., primary, Wittenberg, Courtney, primary, Herzog, Camille, primary, Roschke, Anna V., primary, Demchenko, Yulia N., primary, Chen, Wei-dong D., primary, Li, Peng, primary, Liao, Wei, primary, Leonard, Warren J., primary, Lonial, Sagar, primary, Bahlis, Nizar J., primary, Neri, Paola, primary, Boise, Lawrence H., primary, Chesi, Marta, primary, and Bergsagel, P. Leif, primary

Published
2024
Full Text
View/download PDF

22. Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy

Author

Uson Junior, Pedro Luiz Serrano, Majeed, Umair, Yin, Jun, Botrus, Gehan, Sonbol, Mohamad Bassam, Ahn, Daniel H., Starr, Jason S., Jones, Jeremy C., Babiker, Hani, Inabinett, Samantha R., Wylie, Natasha, Boyle, Ashton W.R., Bekaii-Saab, Tanios S., Gores, Gregory J., Smoot, Rory, Barrett, Michael, Nagalo, Bolni, Meurice, Nathalie, Elliott, Natalie, Petit, Joachim, Zhou, Yumei, Arora, Mansi, Dumbauld, Chelsae, Barro, Oumar, Baker, Alexander, Bogenberger, James, Buetow, Kenneth, Mansfield, Aaron, Mody, Kabir, and Borad, Mitesh J.

Published
2022
Full Text
View/download PDF

23. Transcriptional heterogeneity overcomes super-enhancer disrupting drug combinations in multiple myeloma

Author

Welsh, Seth J., primary, Barwick, Benjamin G., additional, Meermeier, Erin W., additional, Riggs, Daniel L., additional, Shi, Chang-Xin, additional, Zhu, Yuan Xiao, additional, Sharik, Meaghen E., additional, Du, Megan T., additional, Rocha, Leslie D Abrego., additional, Garbitt, Victoria M., additional, Stein, Caleb K., additional, Petit, Joachim L., additional, Meurice, Nathalie, additional, Tafoya Alvarado, Yuliza, additional, Fonseca, Rodrigo, additional, Todd, Kennedi T., additional, Brown, Sochilt, additional, Hammond, Zachary J., additional, Cuc, Nicklus H., additional, Wittenberg, Courtney, additional, Herzog, Camille, additional, Roschke, Anna V., additional, Demchenko, Yulia N., additional, Chen, Wei-dong D., additional, Li, Peng, additional, Liao, Wei, additional, Leonard, Warren J., additional, Lonial, Sagar, additional, Bahlis, Nizar J., additional, Neri, Paola, additional, Boise, Lawrence H., additional, Chesi, Marta, additional, and Bergsagel, P. Leif, additional

Published
2023
Full Text
View/download PDF

24. The Bivalent Bromodomain Inhibitor MT-1 Inhibits Prostate Cancer Growth

Author

Shukla, Sanjeev, primary, Riveros, Carlos, additional, Al-Toubat, Mohammed, additional, Chardon-Robles, Jonathan, additional, Osumi, Teruko, additional, Serrano, Samuel, additional, Kase, Adam M., additional, Petit, Joachim L., additional, Meurice, Nathalie, additional, Gleba, Justyna, additional, Copland, John A., additional, Chauhan, Jay, additional, Fletcher, Steven, additional, and Balaji, K. C., additional

Published
2023
Full Text
View/download PDF

25. “Direct to Drug” screening as a precision medicine tool in multiple myeloma

Author

Bonolo de Campos, Cecilia, Meurice, Nathalie, Petit, Joachim L., Polito, Alysia N., Zhu, Yuan Xiao, Wang, Panwen, Bruins, Laura A., Wang, Xuewei, Lopez Armenta, Ilsel D., Darvish, Susie A., Ahmann, Greg J., Henderson, Kimberly J., Tian, Shulan, Kruse, Jonas J., Stewart, William M., Larsen, Jeremy T., Reeder, Craig B., Dingli, David, Kapoor, Prashant, Kumar, Shaji K., Fonseca, Rafael, Bergsagel, P. Leif, Braggio, Esteban, and Stewart, A. Keith

Published
2020
Full Text
View/download PDF

26. Abstract 2475: Bromodomain inhibitor: MT1 and its potential role in modulation of prostate cancer progression

Author

Shukla, Sanjeev, primary, Al-Toubat, Mohammed, additional, Feibus, Allison H., additional, Elshafei, Ahmed, additional, Riveros, Carlos, additional, Meurice, Nathalie, additional, Gleba, Justyna, additional, Chardon-Robles, Jonathan, additional, Kase, Adam M., additional, III, John A. Copland, additional, Petit, Joachim L., additional, Osumi, Teruko, additional, and Balaji, K.C., additional

Published
2023
Full Text
View/download PDF

27. Data from Molecular Inhibitor of QSOX1 Suppresses Tumor Growth In Vivo

Author

Fifield, Amber L., primary, Hanavan, Paul D., primary, Faigel, Douglas O., primary, Sergienko, Eduard, primary, Bobkov, Andrey, primary, Meurice, Nathalie, primary, Petit, Joachim L., primary, Polito, Alysia, primary, Caulfield, Thomas R., primary, Castle, Erik P., primary, Copland, John A., primary, Mukhopadhyay, Debabrata, primary, Pal, Krishnendu, primary, Dutta, Shamit K., primary, Luo, Huijun, primary, Ho, Thai H., primary, and Lake, Douglas F., primary

Published
2023
Full Text
View/download PDF

28. Supplementary Data from Molecular Inhibitor of QSOX1 Suppresses Tumor Growth In Vivo

Author

Fifield, Amber L., primary, Hanavan, Paul D., primary, Faigel, Douglas O., primary, Sergienko, Eduard, primary, Bobkov, Andrey, primary, Meurice, Nathalie, primary, Petit, Joachim L., primary, Polito, Alysia, primary, Caulfield, Thomas R., primary, Castle, Erik P., primary, Copland, John A., primary, Mukhopadhyay, Debabrata, primary, Pal, Krishnendu, primary, Dutta, Shamit K., primary, Luo, Huijun, primary, Ho, Thai H., primary, and Lake, Douglas F., primary

Published
2023
Full Text
View/download PDF

29. PD04-07 THE BIVALENT BROMODOMAIN INHIBITOR; MT-1 INHIBITS PROSTATE CANCER GROWTH

Author

Shukla, Sanjeev, primary, Al-Toubat, Mohammed, additional, Riveros, Carlos, additional, Feibus, Allison H., additional, El-shafie, Ahmed, additional, Kase, Adam M., additional, Copland, John A., additional, Petit, Joachim L., additional, Meurice, Nathalie, additional, Gleba, Justyna, additional, Chardon-Robles, Jonathan, additional, Osumi, Teruko, additional, and Balaji, K. C., additional

Published
2023
Full Text
View/download PDF

30. MP20-01 PROTEIN KINASE D1 (PrKD) PROTECTS AGAINST DNA DAMAGE BY INCREASING Α-CATENIN LEVELS THROUGH PUTATIVE SERINE681 AND 685 PHOSPHORYLATION OF CYCLIN DEPENDENT KINASE 12 (CDK12) IN PROSTATE CANCER (PC)

Author

Shukla, Sanjeev, primary, Osumi, Teruko, additional, Al-Toubat, Mohammed, additional, Riveros, Carlos, additional, Feibus, Allison H., additional, El-shafie, Ahmed, additional, Kase, Adam M., additional, Copland, John A., additional, Petit, Joachim L., additional, Meurice, Nathalie, additional, Gleba, Justyna, additional, Chardon-Robles, Jonathan, additional, and Balaji, K. C., additional

Published
2023
Full Text
View/download PDF

31. IMiDs Synergize with EP300 Inhibition to Disrupt the Ikzf/MYC/IRF4 Axis in Multiple Myeloma

Author

Welsh, Seth J, primary, Barwick, Benjamin G, additional, Meermeier, Erin, additional, Riggs, Daniel, additional, Shi, Chang-Xin, additional, Zhu, Yuan Xiao, additional, Sharik, Meaghen E, additional, Du, Megan T, additional, Garbitt, Victoria Marie, additional, Stein, Caleb K, additional, Petit, Joachim L, additional, Meurice, Nathalie, additional, Fonseca, Rodrigo, additional, Todd, Kennedi, additional, Brown, Sochilt, additional, Tafoya Alvarado, Yuliza, additional, Hammond, Zachary, additional, Cuc, Nicklus, additional, Wittenberg, Courtney, additional, Herzog, Camille, additional, Boise, Lawrence H., additional, Bahlis, Nizar J., additional, Neri, Paola, additional, Kuehl, W. Michael, additional, Chesi, Marta, additional, and Bergsagel, P. Leif, additional

Published
2022
Full Text
View/download PDF

32. Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers

Author

Nagalo, Bolni Marius, primary, Zhou, Yumei, additional, Loeuillard, Emilien J., additional, Dumbauld, Chelsae, additional, Barro, Oumar, additional, Elliott, Natalie M., additional, Baker, Alexander T., additional, Arora, Mansi, additional, Bogenberger, James M., additional, Meurice, Nathalie, additional, Petit, Joachim, additional, Uson, Pedro Luiz Serrano, additional, Aslam, Faaiq, additional, Raupach, Elizabeth, additional, Gabere, Musa, additional, Basnakian, Alexei, additional, Simoes, Camila C., additional, Cannon, Martin J., additional, Post, Steven R., additional, Buetow, Kenneth, additional, Chamcheu, Jean Christopher, additional, Barrett, Michael T., additional, Duda, Dan G., additional, Jacobs, Bertram, additional, Vile, Richard, additional, Barry, Michael A., additional, Roberts, Lewis R., additional, Ilyas, Sumera, additional, and Borad, Mitesh J., additional

Published
2022
Full Text
View/download PDF

33. Synthesis and highly potent hypolipidemic activity of alpha-asarone- and fibrate-based 2-acyl and 2-alkyl phenols as HMG-CoA reductase inhibitors

Author

Mendieta, Aarón, Jiménez, Fabiola, Garduño-Siciliano, Leticia, Mojica-Villegas, Angélica, Rosales-Acosta, Blanca, Villa-Tanaca, Lourdes, Chamorro-Cevallos, Germán, Medina-Franco, José L., Meurice, Nathalie, Gutiérrez, Rsuini U., Montiel, Luisa E., Cruz, María del Carmen, and Tamariz, Joaquín

Published
2014
Full Text
View/download PDF

36. Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers.

Author

Nagalo, Bolni Marius, Zhou, Yumei, Loeuillard, Emilien J., Dumbauld, Chelsae, Barro, Oumar, Elliott, Natalie M., Baker, Alexander T., Arora, Mansi, Bogenberger, James M., Meurice, Nathalie, Petit, Joachim, Uson Jr, Pedro Luiz Serrano, Aslam, Faaiq, Raupach, Elizabeth, Gabere, Musa, Basnakian, Alexei, Simoes, Camila C., Cannon, Martin J., Post, Steven R., and Buetow, Kenneth

Published
2023
Full Text
View/download PDF

38. Single-Cell Proteomics and Tumor RNAseq Identify Novel Pathways Associated With Clofazimine Sensitivity in PI- and IMiD- Resistant Myeloma, and Putative Stem-Like Cells

Author

Kumar, Harish, primary, Mazumder, Suman, additional, Sharma, Neeraj, additional, Chakravarti, Sayak, additional, Long, Mark D., additional, Meurice, Nathalie, additional, Petit, Joachim, additional, Liu, Song, additional, Chesi, Marta, additional, Sanyal, Sabyasachi, additional, Stewart, A. Keith, additional, Kumar, Shaji, additional, Bergsagel, Leif, additional, Rajkumar, S. Vincent, additional, Baughn, Linda B., additional, Van Ness, Brian G., additional, and Mitra, Amit Kumar, additional

Published
2022
Full Text
View/download PDF

39. Transcriptional profiles define drug refractory disease in myeloma

Author

Zhu, Yuan Xiao, primary, Bruins, Laura A., additional, Chen, Xianfeng, additional, Shi, Chang‐Xin, additional, Bonolo De Campos, Cecilia, additional, Meurice, Nathalie, additional, Wang, Xuewei, additional, Ahmann, Greg J., additional, Ramsower, Colleen A., additional, Braggio, Esteban, additional, Rimsza, Lisa M., additional, and Stewart, A. Keith, additional

Published
2022
Full Text
View/download PDF

41. Characterization of Morreton Virus (MORV) as a Novel Oncolytic Virotherapy Platform for Liver Cancers

Author

Nagalo, Bolni Marius, primary, Zhou, Yumei, additional, Loeuillard, Emilien J., additional, Dumbauld, Chelsae, additional, Barro, Oumar, additional, Elliott, Natalie M., additional, Baker, Alexander T., additional, Arora, Mansi, additional, Bogenberger, James M., additional, Meurice, Nathalie, additional, Petit, Joachim, additional, Uson Junior, Pedro Luiz Serrano, additional, Aslam, Faaiq, additional, Chamcheu, Jean Christopher, additional, Simoes, Camila C., additional, Cannon, Martin J., additional, Basnakian, Alexei, additional, Post, Steven R., additional, Buetow, Kenneth, additional, Barrett, Michael T., additional, Duda, Dan G., additional, Jacobs, Bertram, additional, Vile, Richard, additional, Barry, Michael A., additional, Roberts, Lewis R., additional, Ilyas, Sumera, additional, and Borad, Mitesh J., additional

Published
2022
Full Text
View/download PDF

43. Synergistic combination of cytotoxic chemotherapy and cyclin‐dependent kinase 4/6 inhibitors in biliary tract cancers

Author

Arora, Mansi, primary, Bogenberger, James M., additional, Abdelrahman, Amro M., additional, Yonkus, Jennifer, additional, Alva‐Ruiz, Roberto, additional, Leiting, Jennifer L., additional, Chen, Xianfeng, additional, Serrano Uson Junior, Pedro Luiz, additional, Dumbauld, Chelsae R., additional, Baker, Alexander T., additional, Gamb, Scott I., additional, Egan, Jan B., additional, Zhou, Yumei, additional, Nagalo, Bolni Marius, additional, Meurice, Nathalie, additional, Eskelinen, Eeva‐Liisa, additional, Salomao, Marcela A., additional, Kosiorek, Heidi E., additional, Braggio, Esteban, additional, Barrett, Michael T., additional, Buetow, Kenneth H., additional, Sonbol, Mohamad B., additional, Mansfield, Aaron S., additional, Roberts, Lewis R., additional, Bekaii‐Saab, Tanios S., additional, Ahn, Daniel H., additional, Truty, Mark J., additional, and Borad, Mitesh J., additional

Published
2021
Full Text
View/download PDF

44. FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations

Author

Uson Junior, Pedro Luiz Serrano, primary, DeLeon, Thomas T., additional, Bogenberger, James M., additional, Pai, Rish K., additional, Kosiorek, Heidi E., additional, Yin, Jun, additional, Ahn, Daniel H., additional, Sonbol, Mohammad Bassam, additional, Bekaii-Saab, Tanios, additional, Mansfield, Aaron S., additional, Buetow, Kenneth, additional, Gores, Gregory J., additional, Smoot, Rory, additional, Vasmatzis, George, additional, Kipp, Benjamin R., additional, Mahipal, Amit, additional, Baker, Alexander T., additional, Babiker, Hani, additional, Barro, Oumar, additional, Dumbauld, Chelsae, additional, Zhou, Yumei, additional, Aslam, Faaiq N., additional, Barrett, Michael, additional, Jacobs, Bertram, additional, Meurice, Nathalie, additional, Arora, Mansi, additional, Petit, Joachim, additional, Elliott, Natalie, additional, Nagalo, Bolni, additional, Salomao, Marcela A., additional, and Borad, Mitesh J., additional

Published
2021
Full Text
View/download PDF

45. Cell-Free Tumor DNA Dominant Clone Allele Frequency (DCAF) Is Associated With Poor Outcomes In Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy

Author

Uson Junior, Pedro Luiz Serrano, primary, Majeed, Umair, additional, Yin, Jun, additional, Botrus, Gehan, additional, Sonbol, Mohamad Bassam, additional, Ahn, Daniel H., additional, Starr, Jason S., additional, Jones, Jeremy C, additional, Babiker, Hani, additional, Inabinett, Samantha R, additional, Wylie, Natasha, additional, Boyle, Ashton WR, additional, Bekaii-Saab, Tanios S., additional, Gores, Gregory J, additional, Smoot, Rory, additional, Barrett, Michael, additional, Nagalo, Bolni, additional, Meurice, Nathalie, additional, Elliott, Natalie, additional, Petit, Joachim, additional, Zhou, Yumei, additional, Arora, Mansi, additional, Dumbauld, Chelsae, additional, Barro, Oumar, additional, Baker, Alexander, additional, Bogenberger, James, additional, Buetow, Kenneth, additional, Mansfield, Aaron, additional, Mody, Kabir, additional, and Borad, Mitesh J., additional

Published
2021
Full Text
View/download PDF

47. Protein expression and purification of G-protein coupled receptor kinase 6 (GRK6), toward structure-based drug design and discovery for multiple myeloma

Author

Olson, Tien L., primary, Zhang, Shangji, additional, Labban, Dillon, additional, Kaschner, Emily, additional, Aceves, Manuel, additional, Iyer, Srivatsan, additional, Meza-Aguilar, Jose Domingo, additional, Zook, James D., additional, Chun, Eugene, additional, Craciunescu, Felicia M., additional, Liu, Wei, additional, Shi, Chang-Xin, additional, Stewart, A. Keith, additional, Hansen, Debra T., additional, Meurice, Nathalie, additional, and Fromme, Petra, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results